Immunotherapy Combinations Offer Hope in Glioblastoma – OncLive
OncLive |
Immunotherapy Combinations Offer Hope in Glioblastoma
OncLive Immunotherapy has shown promise for treatment of glioblastoma multiforme (GBM), the most common primary brain tumor in adults with historically poor prognosis, but experts agree that combination regimens have the greatest potential to achieve durable … |
